Aust Ctr for Blood Diseases

    Research areas

  • PET CT, acute MI, animal models of human disease, antibodies, arterial thrombosis, drug delivery systems, microbubbles, molecular imaging, platelets, thrombosis

Monash teaching commitment

HUP3011 - Human pathology: Atherosclerosis

HUP3011 - Human pathology: Vascular biology and disease

IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy

MED2031 - Medicine: Coronary circulation in health and disease

Central Clinical School Honours program "PET / CT Imaging Technology"


Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.

Related Links:

ID: 861004